Preexisting adrenal masses in patients with adrenocortical carcinoma: clinical and radiological factors contributing to delayed diagnosis-Reference-Cited by-同舟云学术

Preexisting adrenal masses in patients with adrenocortical carcinoma: clinical and radiological factors contributing to delayed diagnosis

Published:2015-07-25 Issue:2 Volume:51 Page:351-359
ISSN:1355-008X
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Ozsari Levent,Kutahyalioglu Merve,Elsayes Khaled M.,Vicens Rafael Andres,Sircar Kanishka,Jazaerly Tarek,Waguespack Steven G.,Busaidy Naifa L.,Cabanillas Maria E.,Dadu Ramona,Hu Mimi I.,Vassilopoulou-Sellin Rena,Jimenez Camilo,Lee Jeffrey E.,Habra Mouhammed Amir

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s12020-015-0694-7.pdf

Reference25 articles.

1. E. Kebebew, E. Reiff, Q.Y. Duh, O.H. Clark, A. McMillan, Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress? World J. Surg. 30(5), 872–878 (2006). doi: 10.1007/s00268-005-0329-x

2. T.M. Kerkhofs, R.H. Verhoeven, J.M. Van der Zwan, J. Dieleman, M.N. Kerstens, T.P. Links, L.V. Van de Poll-Franse, H.R. Haak, Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993. Eur. J. Cancer 49(11), 2579–2586 (2013). doi: 10.1016/j.ejca.2013.02.034

3. M.M. Grumbach, B.M. Biller, G.D. Braunstein, K.K. Campbell, J.A. Carney, P.A. Godley, E.L. Harris, J.K. Lee, Y.C. Oertel, M.C. Posner, J.A. Schlechte, H.S. Wieand, Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann. Intern. Med. 138(5), 424–429 (2003)

4. M.A. Zeiger, G.B. Thompson, Q.Y. Duh, A.H. Hamrahian, P. Angelos, D. Elaraj, E. Fishman, J. Kharlip, Association of Clinical Endocrinologists; American Association of Endocrine Surgeons, American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: executive summary of recommendations. Endocr Pract 15(5), 450–453 (2009). doi: 10.4158/EP.15.5.450

5. G. Mansmann, J. Lau, E. Balk, M. Rothberg, Y. Miyachi, S.R. Bornstein, The clinically inapparent adrenal mass: update in diagnosis and management. Endocr. Rev. 25(2), 309–340 (2004). doi: 10.1210/er.2002-0031

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transformation of a Benign Adrenocortical Adenoma to a Metastatic Adrenocortical Carcinoma Is Rare But It Happens;JCEM Case Reports;2024-07-24

2. Adrenal Mass Biopsy in Patients Without Extraadrenal Primary Malignancy: A Multicenter Study;American Journal of Roentgenology;2024-01-17

3. High Filamin a Expression in Adrenocortical Carcinomas Is Associated with a Favourable Tumour Behaviour: A European Multicentric Study;International Journal of Molecular Sciences;2023-11-21

4. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors;European Journal of Endocrinology;2023-06-15

5. Detection of incidental adrenal nodules on computed tomography by radiographers;Radiography;2022-11